Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT04764500

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

Conditions: Extended Spectrum Beta Lactamases (ESBL) E. Coli

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: Yes

Enrollment: 39

Sponsor: University Hospital, Basel, Switzerland

Location: University Hospital Basel, Division of Clinical Microbiology Basel

Summary

This study is to identify and isolate well-defined microbials (non-ESBL E. coli) in an observational setting exploring natural gastrointestinal decolonization of humans colonized with ESBL E. coli.

Eligibility Criteria

Inclusion Criteria: * travelling to Southeast Asia (India, Bhutan, Nepal, Bangladesh, Myanmar, Thailand, Laos, Cambodia, Vietnam) for a maximum of 4 weeks. Exclusion Criteria: * other travelling destinations than mentioned above * antibiotic use at the first sampling time * Participants who are not colonized will serve as a control group for microbiome comparison

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04764500). StuddyBuddy aggregates publicly available trial information.